Med Ed Report briefs: August 2013

Marissa Seligman
Marissa Seligman

Marissa Seligman, chief compliance officer and SVP for regulatory and clinical affairs at Pri-Med since 2002, is set to join Clinical Care Options as COO/GM this month. Lynn Long, Pri-Med president/COO cited Seligman's “steady voice for the value of CME” during a “period of great change” for the profession.

Global Academy for Medical Education, in a joint sponsorship with University of Louisville School of Medicine, launched its Click for Credit activity where primary care clinicians can get CMEs for reading peer-reviewed articles and answering questions. In May, Doximity launched a similar service in collaboration with Cleveland Clinic.

The Association of American Medical Colleges and the American Psychological Association announced a collaboration to expand a free, online collection of mental health educational resources for HCPs and med students.

KnowledgePoint360 split one of its largest agencies, ACUMED, in two, creating Seren Communications, which will provide communication and education services like content development, publication support, meetings and congresses. Melissa Piper will serve as president.
You must be a registered member of MMM to post a comment.

Email Newsletters

What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.

A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.